Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis

被引:63
|
作者
Lv, Tingting [1 ,2 ,3 ]
Chen, Sha [1 ,2 ,3 ]
Li, Min [4 ]
Zhang, Dong [5 ,6 ,7 ]
Kong, Yuanyuan [4 ]
Jia, Jidong [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing 100050, Peoples R China
[2] Beijing Key Lab Translat Med Liver Cirrhosis, Beijing 100050, Peoples R China
[3] Natl Clin Res Ctr Digest Dis, Beijing 100050, Peoples R China
[4] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Clin Epidemiol & EBM Unit, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China
[6] Beijing Clin Res Inst, Beijing, Peoples R China
[7] Beijing Key Lab Tolerance Induct & Organ Protect, Beijing, Peoples R China
关键词
epidemiology; incidence; meta-analysis; prevalence; primary biliary cholangitis; PRIMARY SCLEROSING CHOLANGITIS; AUTOIMMUNE LIVER-DISEASE; NATURAL-HISTORY; CLINICAL-FEATURES; RISK-FACTORS; CIRRHOSIS; PREVALENCE; POPULATION; HEPATITIS; VICTORIA;
D O I
10.1111/jgh.15329
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends. Methods: Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random-effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta-regression, and sensitivity analysis were conducted to find out the cause for heterogeneity. Results: Out of 3974 records identified through database searching, 47 population-based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia-Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60-79). Conclusion: The PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia-Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America.
引用
收藏
页码:1423 / 1434
页数:12
相关论文
共 50 条
  • [21] BIOCHEMICAL RESPONSE TO OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Alomari, Mohammad
    Al Momani, Laith
    El Kurdi, Bara
    Chadalavada, Pravallika
    Babar, Sumbal
    El Iskandarani, Mahmoud
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2020, 158 (06) : S1382 - S1383
  • [22] Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis
    Gazda, Jakub
    Drazilova, Sylvia
    Gazda, Matej
    Janicko, Martin
    Koky, Tomas
    Macej, Marian
    Carbone, Marco
    Jarcuska, Peter
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (10) : 1318 - 1327
  • [23] Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
    Boonstra, Kirsten
    Beuers, Ulrich
    Ponsioen, Cyriel Y.
    JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1181 - 1188
  • [24] Safety and Efficacy of Seladelpar in Treatment of Patients With Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis
    Raja, Adarsh
    Ahmed, Muhammad
    Raja, Sandesh
    Rahman, Hafsah Alim Ur
    Kumar, Mukesh
    Asghar, Muhammad Sohaib
    Kumar, Sumet
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (02) : e194 - e197
  • [25] Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis
    Xu, Chenyi
    Yue, Rensong
    Lv, Xuelian
    Wang, Shengnan
    Du, Mengmeng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Incidence of Primary Sclerosing Cholangitis: a Systematic Review and Meta-Analysis
    Molodecky, Natalie A.
    Kareemi, Hashim
    Parab, Rohan
    Barkema, Herman W.
    Quan, Hude
    Myers, Robert P.
    Kaplan, Gilaad G.
    HEPATOLOGY, 2011, 53 (05) : 1590 - 1599
  • [27] Pharmacological Therapy of Pruritus in Primary Biliary Cholangitis A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Medina-Morales, Esli
    Bernal, Romelia Barba
    Gerger, Heike
    Goyes, Daniela
    Trivedi, Hirsh D.
    Ferrigno, Bryan
    Patwardhan, Vilas
    Bonder, Alan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (02) : 143 - 152
  • [28] Efficacy and Safety of Seladelpar in Primary Biliary Cholangitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Aboeldahb, Moataz
    Marwan, Menna
    Abdallfatah, Abdallfatah
    Abosheaishaa, Hazem
    Abusuliman, Mohammed
    Abdelwahed, Ahmed H.
    Ali, Khaled
    Ismail, Abdellatif
    Eldesouki, Mohamed
    Hassan, Malak A.
    Rahman, Haider
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1372 - S1372
  • [29] Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis
    Giannini, Edoardo G.
    Pasta, Andrea
    Calabrese, Francesco
    Labanca, Sara
    Marenco, Simona
    Pieri, Giulia
    Torres, Maria Corina Plaz
    Strazzabosco, Mario
    LIVER INTERNATIONAL, 2025, 45 (01)
  • [30] Cholangitis following biliary-enteric anastomosis: A systematic review and meta-analysis
    Birgin, Emrullah
    Teoule, Patrick
    Galata, Christian
    Rahbari, Nuh N.
    Reissfelder, Christoph
    PANCREATOLOGY, 2020, 20 (04) : 736 - 745